arginyl-glycyl-aspartic acid has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalman, RL; Douglas, T; Iida, Y; Kitagawa, T; Kosuge, H; McConnell, MV; Uchida, M | 1 |
| Gupta, AS; Huang, G; Kottke-Marchant, K; Lestini, BJ; Marchant, RE; Sagnella, S | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Vascular Diseases
| Article | Year |
|---|---|
RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Abdominal; Carotid Arteries; Carotid Artery Diseases; Disease Models, Animal; Ferric Compounds; Ferritins; Inflammation; Magnetic Resonance Imaging; Male; Mice; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Vascular Diseases | 2017 |
RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system.
Topics: Blood Platelets; Drug Delivery Systems; Humans; Liposomes; Oligopeptides; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Vascular Diseases | 2005 |